If you had put $100 into big US growth stocks on 31 December, 2019, you would now have $111. Shares in these companies are currently trading not so much as though Covid-19 doesn’t exist, but as though its existence has been a positive for their businesses (which you can argue – they’re mostly tech stocks) and as though they were not already overpriced in December (harder to argue). Look at the speed and scale of the recovery of many of these stocks since March – and they are the ones most discussed in the media – and you will have only one thought: “There’s a bubble out there.”
There is still value to be had
But do not for a second think that just because US tech stocks are suffering from a gloriously exuberant bout of optimism bias, there is no long-term value in markets as a whole. There is. In both Europe and the US, says Verdad’s Brian Chingono, cheap stocks are genuinely cheap. Take the cheapest 20% in the market (the “deep value” stocks) and you will see they trade at significant discounts to their long-term averages – in Europe the discount to the 20-year average is 13%, in the US, it is 17% (although European stocks are cheaper in absolute terms).
Look to the UK (now moving out of lockdown fast) as well. Here, even with the many Covid cancellations taken into account, dividend yields are high and valuations perfectly reasonable.
Start your trial of MoneyWeek today
Get unparalleled financial insight, analysis and expert opinion you can profit from.
Start your trial
Sign up for MoneyWeek’s free twice-daily newsletter.
Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.
Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.
Two cheap investment trusts
If you like the idea of cheap (trust me, you do), and you want to find a way to hold some of the market’s most interesting assets at a discount to their net asset value (NAV) you should also listen to our latest podcast with Nick Greenwood of Premier Miton. Greenwood runs a fund of investment trusts, chosen in large part for their price (he looks to buy at a “significant discount to their intrinsic value”). We talk about many of the ones he is interested in at the moment on the podcast but one of particular interest might be Artemis Alpha (LSE: ATS), a trust with a history of making unsuccessful private investments and underperforming as a result. Two years ago it relaunched with new managers. The unlisted holdings have been significantly cut (to below 10%) and matters are much improved. However you can still buy the revamped portfolio at a 19% discount.
Latest Videos FromMoneyWeek
I’m also interested in Henderson Opportunities (LSE: HOT) – run by James Henderson and Laura Foll who also run Law Debenture (one of the trusts in the MoneyWeek model portfolio). This trust is more focused on small caps than the latter and if you have any faith in the stock picking abilities and value bias of the fund managers (which we do) the shares should be pretty interesting on a discount of 20% to their NAV. If investment trusts on discounts are your thing (they probably should be) Max King looks at the private equity sector in this week's magazine.
Finally a reminder that where and whenever you invest you should do so with at least some thought (see John’s Money Morning newsletter from 24 June) – we look this week at the shocking story of what can happen when you don’t. I really hope none of you went into last week holding Wirecard.
